AAIC 2024

Alzheimer's Association International Conference 2024

July 28 - August 1, 2024

Pennsylvania Convention Center - Philadephia, PA, USA

Experience pTau and beyond with the NULISAseq CNS Disease Panel 120 for detection of 120 important CNS disease related proteins with unrivaled sensitivity, plex, and simplicity.

Meet with us at booth #936 and get a demo of the ARGO HT System or schedule time with one of us for a personal demo and to discuss your research goals. 

visit our booth #936

Product Theater

pTau and Beyond- High sensitivity, multiplexed analysis of CNS disease biomarkers from biofluids.

Tuesday, July 30 – 12:25-1:05 PM

Amanda Heslegrave, PhD

Senior Research Associate, Neurodegenerative Diseases
University College London

Thomas Karikari, PhD

Assistant Professor of Psychiatry
Endowed Faculty in Peripheral Biomarkers for Brain Diseases
University of Pittsburgh


Lightning Presentation & Poster
Sunday, July 28, 8:04-8:08am | 118 ABC

#361: Plasma proteomic changes in carriers of progranulin mutations on the novel NULISA platform
J. Simrén, PhD, et al. University of Gothenburg

Featured Research Session
Sunday, July 28, 2:30-2:45pm | Hall A

Multi-analyte measurement of blood biomarkers for Alzheimer’s disease: enabling concurrent analysis of affected pathophysiological processes
Xuemei Zeng PhD, et al. University of Pittsburgh

Featured Research Session
Monday, July 29, 9:48-10am | 118 ABC

CSF and Plasma Proteomics in the AT groups. What is beyond amyloid and p-tau?
Andrea L. Benedet, PhD, et al. University of Gothenburg


Monday, July 29, 8:15am-4:15pm | Exhibit Hall

#236: Plasma biomarkers discrimination accuracy of biologically defined Alzheimer’s disease in a memory clinic setting
Frederica Anastasi, PhD, et al.
Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation

#266: Plasma proteomic profiling in mild cognitive impairment using NULISAseq
Guglielmo Di Molfetta, PhD, et al. University of Gothenburg

#328: Inflammation links in Alzheimer’s Disease: connecting fluid proteomics and TSPO PET
Ilaria Pola, PhD, et al.
University of Gothenburg

#351: Determining APOE ε4 carriership by NUcleic acid Linked Immuno-Sandwich Assay
Kübra Tan, PhD, et al.
University of Gothenburg

#847: Validation of the plasma phosphorylated tau quantified using NUcleic acid Linked Immuno-Sandwich Assay (NULISA) for the detection of Alzheimer’s disease pathology
Yi-Ting Wang
McGill University Research Centre for Studies in Aging

Wednesday, July 31, 8:15am-4:15pm | Exhibit Hall

#315: Development of NULISAseq™ CNS Disease Panel 120 for comprehensive proteomics profiling of neurodegenerative diseases
Xiao-Jun Ma, PhD, et al. Alamar Biosciences